The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 10, 2020

Filed:

May. 14, 2019
Applicant:

Stc.unm, Albuquerque, NM (US);

Inventors:

Graham Timmins, Albuquerque, NM (US);

Vojo P. Deretic, Placitas, NM (US);

Assignee:

Other;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/137 (2006.01); A61P 11/00 (2006.01); A61P 31/06 (2006.01); A61K 31/136 (2006.01); A61K 35/00 (2006.01); A61K 51/04 (2006.01); C07C 213/08 (2006.01); A61K 31/395 (2006.01); A61K 9/00 (2006.01); C07C 215/42 (2006.01); C07B 59/00 (2006.01); A61P 31/04 (2006.01); C07C 215/68 (2006.01); A61K 45/06 (2006.01); A61K 45/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/137 (2013.01); A61K 9/0075 (2013.01); A61K 31/136 (2013.01); A61K 31/395 (2013.01); A61K 35/00 (2013.01); A61K 45/06 (2013.01); A61K 51/0402 (2013.01); A61P 11/00 (2018.01); A61P 31/04 (2018.01); A61P 31/06 (2018.01); C07B 59/001 (2013.01); C07C 213/08 (2013.01); C07C 215/42 (2013.01); C07C 215/68 (2013.01); A61K 45/00 (2013.01);
Abstract

The present invention is directed toH isotope enhanced ambroxol ('isotope enhanced ambroxol') and its use in the treatment of autophagy infections, especially mycobacterial and other infections, disease states and/or conditions of the lung, such as tuberculosis, especially including drug resistant and multiple drug resistant tuberculosis. Pharmaceutical compositions comprising isotope enhanced ambroxol, alone or in combination with an additional bioactive agent, especially rifamycin antibiotics, including an additional autophagy modulator (an agent which is active to promote or inhibit autophagy) are also disclosed. These compositions are useful against an autophagy mediated disease state and/or condition), especially an autophagy mediated disease state and/or condition which occurs in the lungs.


Find Patent Forward Citations

Loading…